The Case for Selective Withdrawal of Antidepressants in Patients with Advanced Kidney Disease
Author(s) -
Joseph Chilcot,
Ken Farrington
Publication year - 2019
Publication title -
journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.451
H-Index - 279
eISSN - 1533-3450
pISSN - 1046-6673
DOI - 10.1681/asn.2019030308
Subject(s) - escitalopram , sertraline , medicine , citalopram , randomized controlled trial , kidney disease , dialysis , paroxetine , comorbidity , adverse effect , context (archaeology) , antidepressant , psychiatry , paleontology , biology , hippocampus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom